샘플 요청 목록

 카트 문의
시장보고서
상품코드
1577495

세계의 두경부암 진단 시장

Head and Neck Cancer Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 296 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

두경부암 진단 세계 시장은 2030년까지 152억 달러에 달할 것으로 전망

2023년 68억 달러로 추정되는 두경부암 진단 세계 시장은 2023-2030년 분석 기간 동안 연평균 12.1% 성장하여 2030년에는 152억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 생검 및 혈액 검사는 CAGR 13.0%를 기록하여 분석 기간이 끝날 때까지 62억 달러에 도달할 것으로 예상됩니다. 영상 진단 분야의 성장률은 분석 기간 동안 CAGR 12.1%로 추정됩니다.

미국 시장 19억 달러로 추정, 중국은 CAGR 16.5%로 성장 전망

미국의 두경부암 진단 시장은 2023년 19억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 33억 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 16.5%의 CAGR을 기록할 것으로 예측됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 9.0%와 10.6%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 9.6%의 성장률을 보일 것으로 예상됩니다.

세계 두경부암 진단 시장 - 주요 동향 및 촉진요인 요약

두경부암 진단 기술은 어떻게 두경부암을 발견할 수 있을까?

진단 기술의 발전으로 두경부암을 조기에 정확하게 발견할 수 있게 되었습니다. 영상 진단, 생검, 분자 검사 등 최신 진단 기술은 두경부암을 조기에 발견하는 능력을 크게 향상시켜 환자의 예후를 크게 개선했으며, PET, MRI, CT 스캔과 같은 영상 진단 기술은 종양을 식별하고 모니터링하는 데 널리 사용되어 암이 퍼진 위치와 범위에 대한 자세한 인사이트를 제공합니다. 암의 확산 위치와 범위에 대한 자세한 인사이트를 제공합니다. 또한, 분자진단학은 이러한 암과 관련된 특정 유전자 돌연변이 및 바이오마커를 식별함으로써 두경부암 진단의 판도를 바꾸고 있습니다. 혈액 내 순환 종양 DNA를 검출할 수 있는 액체 생검과 같은 치료 기술은 기존의 조직 생검을 대체할 수 있는 덜 침습적인 대안을 제공하여 조기 발견과 보다 맞춤화된 치료 옵션을 가능하게 하고 있습니다. 이러한 치료법의 발전은 진단의 정확성을 높이고, 임상의가 환자 개개인에게 가장 적합한 치료법을 선택할 수 있도록 도와주며, 그 과정에서 생존율도 향상되고 있습니다.

두경부암 진단의 미래를 형성하는 혁신은 무엇일까?

기술 혁신은 두경부암 진단의 진화를 촉진하여 암을 조기에 발견하고 환자 개개인의 필요에 맞는 치료를 용이하게 하고 있습니다. 중요한 발전 중 하나는 종양의 유전자 돌연변이와 이상을 포괄적으로 분석할 수 있는 차세대 염기서열 분석(NGS) 기술의 등장으로, NGS는 암의 분자 프로파일에 대한 자세한 정보를 제공하여 의사가 다양한 치료에 대한 반응을 예측하는 데 도움을 줍니다. 또 다른 주요 혁신은 인공지능(AI) 기반 진단 도구로, 임상의가 영상 진단 결과와 유전자 정보를 포함한 복잡한 데이터 세트를 분석하여 임상의가 더 빠르고 정확한 진단을 내릴 수 있도록 돕기 위해 개발되고 있습니다. 이러한 AI 기반 시스템은 사람의 눈으로는 간과할 수 있는 패턴을 감지할 수 있어 악성 종양을 조기에 발견할 수 있습니다. 또한, 현장에서 신속하게 검사할 수 있는 현장 진단은 특히 첨단 의료 인프라에 대한 접근성이 제한적인 지역에서 인기를 끌고 있습니다. 이러한 기술의 비약적인 발전은 두경부암 진단을 보다 개인화되고 효율적인 의료 서비스로 발전시키고 있습니다.

소비자 및 헬스케어 트렌드의 변화가 두경부암 진단 수요에 어떤 영향을 미치고 있는가?

소비자 의식과 헬스케어 트렌드는 두경부암 진단 수요 형성에 중요한 역할을 하고 있습니다. 예방의학에 대한 관심이 높아지면서, 특히 흡연자나 인유두종바이러스(HPV) 감염자 등 고위험군들은 두경부암 검진을 적극적으로 받고 있습니다. 조기 발견과 담배의 위험성에 대한 인식 개선 캠페인이 활발해지면서, 특히 의료 시스템이 잘 갖춰진 선진국에서는 진단 서비스를 받는 사람이 늘고 있습니다. 또한, 두경부암은 노년층에서 많이 발생하기 때문에 전 세계적으로 고령화가 두경부암 환자 증가에 기여하고 있습니다. 의료 서비스 제공자들이 환자의 예후를 개선하고 치료 비용을 절감하기 위해 조기 진단에 중점을 두면서 종합적인 진단 서비스에 대한 수요는 지속적으로 증가하고 있으며, 이는 시장 성장을 견인하고 있습니다.

두경부암 진단 시장의 성장을 촉진하는 요인은 무엇일까?

두경부암 진단 시장의 성장은 기술 발전, 암 발병률 증가, 의료 정책의 발전과 관련된 여러 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 액체 생검, 차세대 시퀀싱, AI 기반 이미징과 같은 첨단 진단 기술의 채택이 증가함에 따라 암을 조기에 정확하게 발견할 수 있게 되었다는 점입니다. 또한, 두경부암, 특히 HPV와 관련된 암 발병률의 증가로 인해 의료 서비스 제공자와 정부가 검진에 집중하고 있는 것도 시장 규모를 확대하는 요인입니다. 병원, 진단센터, 연구기관이 정확하고 비침습적인 암 검진에 대한 수요를 충족시키기 위해 이러한 기술을 채택함에 따라 최종 용도가 확대되고 있습니다. 또한, 환자의 종양 유전적 구성에 따라 치료 계획을 세우는 개인 맞춤형 의료로의 전환으로 분자진단의 필요성이 증가하고 있습니다. 암의 조기 발견을 촉진하는 규제 프레임워크와 세계 헬스케어 지출 증가는 첨단 진단 기술의 채택을 더욱 가속화하여 이 시장을 확대하고 빠르게 발전시키고 있습니다.

조사 대상 기업 사례(총 53건)

  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • Merck KGaA
  • Moffitt Cancer Center
  • oncgnostics GmbH
  • Pfizer, Inc.
  • Sarah Cannon
  • Shimadzu Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.10.29

Global Head and Neck Cancer Diagnostics Market to Reach US$15.2 Billion by 2030

The global market for Head and Neck Cancer Diagnostics estimated at US$6.8 Billion in the year 2023, is expected to reach US$15.2 Billion by 2030, growing at a CAGR of 12.1% over the analysis period 2023-2030. Biopsy & Blood Tests, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth in the Imaging segment is estimated at 12.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 16.5% CAGR

The Head and Neck Cancer Diagnostics market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 16.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 10.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Global Head and Neck Cancer Diagnostics Market - Key Trends & Drivers Summarized

How Are Diagnostic Technologies Advancing the Detection of Head and Neck Cancer?

The early and accurate detection of head and neck cancer is becoming increasingly achievable thanks to advancements in diagnostic technologies. Modern diagnostic techniques, including imaging, biopsies, and molecular testing, have vastly improved the ability to detect these cancers in their earlier stages, significantly improving patient outcomes. Imaging technologies such as PET, MRI, and CT scans are widely used to identify and monitor tumors, providing detailed insights into the location and extent of cancer spread. Additionally, molecular diagnostics are transforming the landscape of head and neck cancer diagnostics by identifying specific genetic mutations and biomarkers linked to these cancers. Technologies such as liquid biopsy, which can detect circulating tumor DNA in the blood, offer less invasive alternatives to traditional tissue biopsies, allowing for earlier detection and more personalized treatment options. These advancements are enhancing the precision of diagnoses, helping clinicians choose the most appropriate treatments for individual patients, and improving survival rates in the process.

What Innovations Are Shaping the Future of Head and Neck Cancer Diagnostics?

Technological innovations continue to drive the evolution of head and neck cancer diagnostics, making it easier to identify cancer at an early stage and tailor treatments to individual patient needs. One significant advancement is the rise of next-generation sequencing (NGS) technology, which allows for the comprehensive analysis of genetic mutations and abnormalities in tumors. NGS provides detailed information about the cancer’s molecular profile, helping doctors predict how it will respond to different treatments. Another key innovation is artificial intelligence (AI)-driven diagnostic tools, which are being developed to analyze complex datasets, including imaging results and genetic information, to assist clinicians in making faster and more accurate diagnoses. These AI-powered systems can detect patterns that may be missed by the human eye, leading to earlier identification of malignancies. Additionally, point-of-care diagnostics, which enable rapid, on-site testing, are gaining popularity, particularly in regions with limited access to advanced healthcare infrastructure. These technological breakthroughs are propelling head and neck cancer diagnostics towards more personalized and efficient care.

How Are Changing Consumer and Healthcare Trends Impacting the Demand for Head and Neck Cancer Diagnostics?

Consumer awareness and healthcare trends are playing a vital role in shaping the demand for head and neck cancer diagnostics. With an increasing focus on preventive healthcare, patients are more proactive in seeking screenings for cancers, including those of the head and neck, particularly when they fall into high-risk categories such as smokers or individuals exposed to the human papillomavirus (HPV). Rising awareness campaigns around early detection and the dangers of tobacco use have prompted a greater number of individuals to seek diagnostic services, particularly in developed regions with robust healthcare systems. Moreover, the aging global population is contributing to the rise in head and neck cancer cases, as these cancers are more common in older adults. As healthcare providers place more emphasis on early diagnosis to improve patient outcomes and reduce the cost of late-stage treatments, the demand for comprehensive diagnostic services continues to increase, driving growth in this market.

What Factors Are Driving Growth in the Head and Neck Cancer Diagnostics Market?

The growth in the head and neck cancer diagnostics market is driven by several factors related to technological advancements, rising cancer incidence, and evolving healthcare policies. One of the primary drivers is the increasing adoption of advanced diagnostic technologies such as liquid biopsy, next-generation sequencing, and AI-powered imaging, which allow for earlier and more accurate cancer detection. The rising incidence of head and neck cancers, particularly those linked to HPV, has also expanded the market's scope, as healthcare providers and governments focus on screening initiatives. End-use applications are growing as hospitals, diagnostic centers, and research institutes adopt these technologies to meet the demand for precise and non-invasive cancer detection. Additionally, the shift towards personalized medicine, which emphasizes treatment plans tailored to the genetic makeup of a patient’s tumor, is boosting the need for molecular diagnostics. Regulatory frameworks promoting early cancer detection and the global rise in healthcare expenditures are further accelerating the adoption of advanced diagnostics, making this an expanding and rapidly evolving market.

Select Competitors (Total 53 Featured) -

  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • Merck KGaA
  • Moffitt Cancer Center
  • oncgnostics GmbH
  • Pfizer, Inc.
  • Sarah Cannon
  • Shimadzu Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Head and Neck Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Head and Neck Cancers Drives Demand for Early Detection and Diagnostic Solutions
    • Technological Advancements in Imaging Techniques Propel Growth in Head and Neck Cancer Diagnostics
    • Growing Adoption of Liquid Biopsy and Molecular Testing Expands Opportunities in Precision Diagnostics
    • Increasing Focus on Personalized Medicine and Targeted Therapies Boosts Demand for Diagnostic Testing
    • Expanding Use of Biomarkers and Genetic Profiling Strengthens the Business Case for Advanced Diagnostics
    • Rising Awareness of Human Papillomavirus (HPV) as a Major Risk Factor Expands Screening Programs
    • Government Initiatives and Cancer Prevention Programs Propel Demand for Early Detection Technologies
    • Technological Innovations in Artificial Intelligence and Machine Learning Drive Accuracy in Diagnostic Imaging
    • Increasing Adoption of Non-Invasive Diagnostic Techniques Expands Market for Early Cancer Detection
    • Growing Focus on Tumor Heterogeneity and Genetic Mutations Fuels Demand for Advanced Molecular Diagnostics
    • Rising Demand for Companion Diagnostics in Cancer Treatment Strengthens the Role of Precision Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Head and Neck Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Head and Neck Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Head and Neck Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Biopsy & Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Biopsy & Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Biopsy & Blood Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Dental Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Dental Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Dental Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Head and Neck Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Head and Neck Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Head and Neck Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Head and Neck Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Head and Neck Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Head and Neck Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Head and Neck Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Head and Neck Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Head and Neck Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Head and Neck Cancer Diagnostics by Method - Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Head and Neck Cancer Diagnostics by Method - Percentage Breakdown of Value Sales for Biopsy & Blood Tests, Imaging, Endoscopy and Dental Diagnostics for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Head and Neck Cancer Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Head and Neck Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제